Below are the most recent publications written about "Nanoparticles" by people in Profiles.
-
Guri-Lamce I, AlRokh Y, Kim Y, Maeshima R, Graham C, Hart SL, McGrath JA, Jack?w-Malinowska J. Topical gene editing therapeutics using lipid nanoparticles: 'gene creams' for genetic skin diseases? Br J Dermatol. 2024 Apr 17; 190(5):617-627.
-
Zhang SS, Li RQ, Chen Z, Wang XY, Dumont AS, Fan X. Immune cells: potential carriers or agents for drug delivery to the central nervous system. Mil Med Res. 2024 Mar 29; 11(1):19.
-
Korzun T, Moses AS, Kim J, Patel S, Schumann C, Levasseur PR, Diba P, Olson B, Rebola KGO, Norgard M, Park Y, Demessie AA, Eygeris Y, Grigoriev V, Sundaram S, Pejovic T, Brody JR, Taratula OR, Zhu X, Sahay G, Marks DL, Taratula O. Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated Cachexia. Small. 2022 11; 18(44):e2204436.
-
Ndeupen S, Bouteau A, Herbst C, Qin Z, Jacobsen S, Powers NE, Hutchins Z, Kurup D, Diba LZ, Watson M, Ramage H, Igyártó BZ. Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses. PLoS Pathog. 2022 01; 18(1):e1010255.
-
Thangavel K, Lakshmikuttyamma A, Thangavel C, Shoyele SA. CD44-targeted, indocyanine green-paclitaxel-loaded human serum albumin nanoparticles for potential image-guided drug delivery. Colloids Surf B Biointerfaces. 2022 Jan; 209(Pt 1):112162.
-
Zhang D, Atochina-Vasserman EN, Maurya DS, Huang N, Xiao Q, Ona N, Liu M, Shahnawaz H, Ni H, Kim K, Billingsley MM, Pochan DJ, Mitchell MJ, Weissman D, Percec V. One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA. J Am Chem Soc. 2021 08 11; 143(31):12315-12327.
-
Igy?rt? BZ, Jacobsen S, Ndeupen S. Future considerations for the mRNA-lipid nanoparticle vaccine platform. Curr Opin Virol. 2021 06; 48:65-72.
-
Sawamoto K, ?lvarez JV, Herre?o AM, Otero-Espinar FJ, Couce ML, Alm?ciga-D?az CJ, Tomatsu S. Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders. Curr Osteoporos Rep. 2020 10; 18(5):515-525.
-
Yellepeddi VK, Joseph A, Nance E. Pharmacokinetics of nanotechnology-based formulations in pediatric populations. Adv Drug Deliv Rev. 2019 Nov - Dec; 151-152:44-55.
-
Facciol? A, Visalli G, Lagan? P, La Fauci V, Squeri R, Pellican? GF, Nunnari G, Trovato M, Di Pietro A. The new era of vaccines: the "nanovaccinology". Eur Rev Med Pharmacol Sci. 2019 Aug; 23(16):7163-7182.